Top Markets
Coin of the day
CSL Limited CSL Limited

CSL Limited

CSL
Rang in Aktien #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Aktienkurs
$99.32
Marktkapitalisierung
$48.20B
Veränderung (1 Tag)
0.98%
Veränderung (1 Jahr)
-32.14%
Land
AU
Handel CSL Limited (CSL)

Kategorie

Kursverlauf für CSL Limited (CSL)
Höchster Schlusskurs: $99.95 am 2026-03-01

Niedrigster Schlusskurs: $0.55 am 1994-05-01
Kursverlauf der Aktie von CSL Limited von 1994 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 13.01%
2025 -33.08%
2024 -3.77%
2023 -7.04%
2022 -5.69%
2021 -4.35%
2020 13.64%
2019 48.92%
2018 19.64%
2017 51.86%
2016 -2.99%
2015 3.42%
2014 17.66%
2013 7.48%
2012 72.85%
2011 -9.62%
2010 27.38%
2009 31.88%
2008 -30.73%
2007 91.49%
2006 59.38%
2005 39.53%
2004 69.70%
2003 11.09%
2002 -54.53%
2001 23.70%
2000 43.48%
1999 74.26%
1998 29.88%
1997 51.86%
1996 75.17%
1995 46.22%
1994 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$35.14 -42.95%
DK
$440.41 -6.77%
US
$749.56 34.62%
US
$300.57 84.76%
BE
$700.87 27.68%
NL